Retarding Progression of Myopia with Seasonal Modification of Topical Atropine

Overview

Journal J Ophthalmic Vis Res

Specialty Ophthalmology

Date 2012 Jun 28

PMID 22737334

Citations 7

Authors

Paul Cs Lu

Jackie Cl Chen

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate whether seasonal modification in the concentration of atropine drops is effective in retarding the progression of myopia.

Methods: Two hundred and forty eyes of 120 healthy preschool- and school-age children in Chiayi region, Taiwan were recruited. The treatment group consisted of 126 eyes of 63 children who received atropine eye drops daily for one year and the control group included 114 eyes of 57 children who received nothing. The concentration of atropine eye drops was modified by seasonal variation as follows: 0.1% for summer, 0.25% for spring and fall, and 0.5% for winter. Refractive error, visual acuity, intraocular pressure (IOP), and axial length were evaluated before and after intervention.

Results: Mean age was 9.1±2.8 years in the atropine group versus 9.3±2.8 years in controls (P=0.88). Mean spherical equivalent, refractive error and astigmatism were -1.90±1.66 diopters (D) and -0.50±0.59 D in the atropine group; corresponding values in the control group were -2.09±1.67 D (P=0.97) and -0.55±0.60 D (P=0.85), respectively. After one year, mean progression of myopia was 0.28±0.75 D in the atropine group vs 1.23±0.44 D in controls (P<0.001). Myopic progression was significantly correlated with an increase in axial length in both atropine (r=0.297, P=0.001) and control (r=0.348, P<0.001) groups. No correlation was observed between myopic progression and IOP in either study group.

Conclusion: Modifying the concentration of atropine drops based on seasonal variation, seems to be effective and tolerable for retarding myopic progression in preschool- to school-age children.

Citing Articles

Impact of atropine use for myopia control on intraocular pressure in children: A comprehensive review including postpupil dilation intraocular pressure changes.

Chen P, Hsia Y, Tsai T, Su C, Huang J, Wang T Taiwan J Ophthalmol. 2024; 14(2):179-189.

PMID: 39027062 PMC: 11254001. DOI: 10.4103/tjo.TJO-D-24-00026.

Interventions for myopia control in children: a living systematic review and network meta-analysis.

Lawrenson J, Shah R, Huntjens B, Downie L, Virgili G, Dhakal R Cochrane Database Syst Rev. 2023; 2:CD014758.

PMID: 36809645 PMC: 9933422. DOI: 10.1002/14651858.CD014758.pub2.

Short-term refractive and ocular parameter changes after topical atropine.

Ho M, Hsieh Y, Shen E, Hsu W, Cheng H Taiwan J Ophthalmol. 2020; 10(2):111-115.

PMID: 32874839 PMC: 7442094. DOI: 10.4103/tjo.tjo_110_18.

Interventions to slow progression of myopia in children.

Walline J, Lindsley K, Vedula S, Cotter S, Mutti D, Ng S Cochrane Database Syst Rev. 2020; 1:CD004916.

PMID: 31930781 PMC: 6984636. DOI: 10.1002/14651858.CD004916.pub4.

A Review of Current Concepts of the Etiology and Treatment of Myopia.

Cooper J, Tkatchenko A Eye Contact Lens. 2018; 44(4):231-247.

PMID: 29901472 PMC: 6023584. DOI: 10.1097/ICL.0000000000000499.

References

Lin L, Shih Y, Tsai C, Chen C, Lee L, Hung P . Epidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995. Optom Vis Sci. 1999; 76(5):275-81. DOI: 10.1097/00006324-199905000-00013. View

Katz J, Tielsch J, Sommer A . Prevalence and risk factors for refractive errors in an adult inner city population. Invest Ophthalmol Vis Sci. 1997; 38(2):334-40. View

Siatkowski R, Cotter S, Miller J, Scher C, Crockett R, Novack G . Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study. Arch Ophthalmol. 2004; 122(11):1667-74. DOI: 10.1001/archopht.122.11.1667. View

Mitchell P, Hourihan F, Sandbach J, Wang J . The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology. 1999; 106(10):2010-5. DOI: 10.1016/s0161-6420(99)90416-5. View

Shih Y, Chen C, Chou A, Ho T, Lin L, Hung P . Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther. 1999; 15(1):85-90. DOI: 10.1089/jop.1999.15.85. View

Yap M, Wu M, Liu Z, Lee F, Wang S . Role of heredity in the genesis of myopia. Ophthalmic Physiol Opt. 1993; 13(3):316-9. DOI: 10.1111/j.1475-1313.1993.tb00479.x. View

Saw S, Katz J, Schein O, Chew S, Chan T . Epidemiology of myopia. Epidemiol Rev. 1996; 18(2):175-87. DOI: 10.1093/oxfordjournals.epirev.a017924. View

Chua W, Balakrishnan V, Chan Y, Tong L, Ling Y, Quah B . Atropine for the treatment of childhood myopia. Ophthalmology. 2006; 113(12):2285-91. DOI: 10.1016/j.ophtha.2006.05.062. View

Fan D, Lam D, Chan C, Fan A, Cheung E, Rao S . Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study. Jpn J Ophthalmol. 2007; 51(1):27-33. DOI: 10.1007/s10384-006-0380-7. View

10.

Chou A, Shih Y, Ho T, Lin L . The effectiveness of 0.5% atropine in controlling high myopia in children. J Ocul Pharmacol Ther. 1997; 13(1):61-7. DOI: 10.1089/jop.1997.13.61. View

11.

Saw S, Shih-Yen E, Koh A, Tan D . Interventions to retard myopia progression in children: an evidence-based update. Ophthalmology. 2002; 109(3):415-21; discussion 422-4; quiz 425-6, 443. DOI: 10.1016/s0161-6420(01)00972-1. View

12.

Farbrother J, Kirov G, Owen M, Pong-Wong R, Haley C, Guggenheim J . Linkage analysis of the genetic loci for high myopia on 18p, 12q, and 17q in 51 U.K. families. Invest Ophthalmol Vis Sci. 2004; 45(9):2879-85. DOI: 10.1167/iovs.03-1156. View

13.

Lind G, Chew S, Marzani D, Wallman J . Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes. Invest Ophthalmol Vis Sci. 1998; 39(12):2217-31. View

14.

Wang I, Shih Y, Tseng H, Huang S, Lin L, Hung P . The effect of intravitreal injection of atropine on the proliferation of scleral chondrocyte in vivo. J Ocul Pharmacol Ther. 1998; 14(4):337-43. DOI: 10.1089/jop.1998.14.337. View

15.

Tong L, Huang X, Koh A, Zhang X, Tan D, Chua W . Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology. 2009; 116(3):572-9. DOI: 10.1016/j.ophtha.2008.10.020. View

16.

Chiang M, Kouzis A, Pointer R, Repka M . Treatment of childhood myopia with atropine eyedrops and bifocal spectacles. Binocul Vis Strabismus Q. 2001; 16(3):209-15. View

17.

Jensen H . Timolol maleate in the control of myopia. A preliminary report. Acta Ophthalmol Suppl (1985). 1988; 185:128-9. DOI: 10.1111/j.1755-3768.1988.tb02686.x. View

18.

Luu C, Lau A, Koh A, Tan D . Multifocal electroretinogram in children on atropine treatment for myopia. Br J Ophthalmol. 2005; 89(2):151-3. PMC: 1772532. DOI: 10.1136/bjo.2004.045526. View

19.

Tigges M, Iuvone P, Fernandes A, SUGRUE M, Mallorga P, Laties A . Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys. Optom Vis Sci. 1999; 76(6):397-407. DOI: 10.1097/00006324-199906000-00020. View

20.

BEDROSSIAN R . The effect of atropine on myopia. Ophthalmology. 1979; 86(5):713-9. DOI: 10.1016/s0161-6420(79)35455-0. View